TARALLO, Roberta
 Distribuzione geografica
Continente #
AS - Asia 7.169
NA - Nord America 4.034
EU - Europa 1.421
SA - Sud America 183
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 12.847
Nazione #
HK - Hong Kong 5.645
US - Stati Uniti d'America 3.969
SG - Singapore 751
IT - Italia 459
CN - Cina 388
RU - Federazione Russa 243
DE - Germania 179
BR - Brasile 160
UA - Ucraina 139
VN - Vietnam 124
IE - Irlanda 87
SE - Svezia 73
KR - Corea 69
TR - Turchia 69
FI - Finlandia 60
GB - Regno Unito 52
CA - Canada 44
IN - India 40
NL - Olanda 28
JP - Giappone 24
PL - Polonia 24
ES - Italia 16
MX - Messico 15
AT - Austria 14
AR - Argentina 13
BD - Bangladesh 12
CZ - Repubblica Ceca 11
ZA - Sudafrica 10
IQ - Iraq 7
FR - Francia 6
ID - Indonesia 6
UZ - Uzbekistan 6
CH - Svizzera 5
PK - Pakistan 5
SA - Arabia Saudita 5
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
EU - Europa 3
HR - Croazia 3
KE - Kenya 3
LT - Lituania 3
MA - Marocco 3
OM - Oman 3
AU - Australia 2
BE - Belgio 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
IL - Israele 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
CV - Capo Verde 1
DK - Danimarca 1
EE - Estonia 1
GM - Gambi 1
GR - Grecia 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NR - Nauru 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SD - Sudan 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 12.847
Città #
Hong Kong 5.638
Ann Arbor 715
Dallas 511
Chandler 407
Singapore 376
Woodbridge 235
Ashburn 225
Princeton 225
Jacksonville 189
Wilmington 179
Houston 158
Salerno 128
Dublin 83
Beijing 82
Munich 76
Izmir 54
Naples 54
Andover 50
The Dalles 50
Los Angeles 45
Nanjing 41
New York 41
Boardman 37
Dearborn 36
Moscow 35
Ho Chi Minh City 33
Dong Ket 32
Turku 29
Fairfield 27
Pellezzano 27
Santa Clara 25
Shenyang 24
Hanoi 23
Tokyo 21
Warsaw 21
Columbus 18
Hebei 18
Montreal 18
Brooklyn 17
Nuremberg 17
San Jose 17
São Paulo 17
Washington 17
Atlanta 16
Stockholm 16
Changsha 15
Orem 14
Chicago 13
Fisciano 13
London 13
Mercato San Severino 13
Nürnberg 13
Denver 12
Seattle 12
Boston 11
Brno 11
San Francisco 11
Amsterdam 10
Chennai 10
Guangzhou 10
Milan 10
Phoenix 10
Düsseldorf 9
Poplar 9
Pune 9
Tianjin 9
Vienna 9
Ankara 8
Cambridge 8
Nanchang 8
Norwalk 8
Jinan 7
Redwood City 7
Renton 7
Seoul 7
Zhengzhou 7
Calgary 6
Frankfurt am Main 6
Jiaxing 6
Johannesburg 6
Manchester 6
Pisa 6
Rome 6
Toronto 6
Council Bluffs 5
Da Nang 5
Esslingen am Neckar 5
Falls Church 5
Mele 5
Mexico City 5
Rio de Janeiro 5
San Giorgio A Cremano 5
Tashkent 5
Arzano 4
Bari 4
Charlotte 4
Edinburgh 4
Jakarta 4
Jeddah 4
Napoli 4
Totale 10.537
Nome #
Small non-coding RNA deregulation in endometrial carcinogenesis 1.095
The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei 699
Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: Identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics. 529
Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer 475
WIND (Workflow for pIRNAs aNd beyonD): a strategy for in-depth analysis of small RNA-seq data 469
Global View of Candidate Therapeutic Target Genes in Hormone-Responsive Breast Cancer 463
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis 449
Estrogen Receptor α Controls a Gene Network in Luminal-like Breast Cancer Cells Comprising Multiple Transcription Factors and microRNAs. 439
Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy 427
Host nasopharyngeal transcriptome dataset of a SARS-CoV-2 positive Italian cohort 422
Small non-coding RNA transcriptomic profiling in adult and fetal human brain 315
Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer 213
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers 211
Splicing of platelet resident pre-mRNAs upon activation by physiological stimuli results in functionally relevant proteome modifications. 204
Identification of Genes Selectively Regulated in Human Hepatoma Cells by Treatment With Dyslipidemic Sera and PUFAs 193
Identification of cytoplasmic proteins interacting with unliganded estrogen receptor α and β in human breast cancer cells 184
iSmaRT: a toolkit for a comprehensive analysis of small RNA-Seq data 183
The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading 182
Activation of Farnesoid X Receptor Impairs The Tumor-Promoting Function of Breast Cancer-Associated Fibroblasts 169
Higher integrin alpha 3 beta1 expression in papillary thyroid cancer is associated with worst outcome 169
Effects of Oestrogen on MicroRNA Expression in Hormone-Responsive Breast Cancer Cells 157
A large set of estrogen receptor beta-interacting proteins identified by tandem affinity purification in hormone-responsive human breast cancer cells nuclei. 153
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 152
Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations. 148
Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies 145
Global Analysis of Estrogen Receptor Beta Binding to Breast Cancer Cell Genome Reveals Extensive Interplay with Estrogen Receptor Alpha for Target Gene Regulation. 145
Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. 142
Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma 137
Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cells. 136
Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells 136
Carcinogenic risk and Bisphenol A exposure: A focus on molecular aspects in endoderm derived glands 128
New Insights on Estrogen Receptor Actions in Hormone-responsive Breast Cancer Cells by Interaction Proteomics 124
Timed regulation of P-Element-Induced Wimpy Testis-interacting RNA expression during rat liver regeneration. 118
Post-transcriptional regulation of human breast cancer cell proteome by unliganded Estrogen Receptor beta via microRNAs. 117
Identification of long non‑coding RNA expression patterns useful for molecular‑based classification of type I endometrial cancers 116
Identification of a hormone-regulated dynamic actin network associated with estrogen receptor alpha in human breast cancer cell nuclei. 115
Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy 115
Histone macroH2A1.2 promotes metabolic health and leanness by inhibiting adipogenesis 114
Relations of gut liver axis components and gut microbiota in obese children with fatty liver: A pilot study 113
Identification of proteins associated with ligand-activated estrogen receptor alpha in human breast cancer cell nuclei by tandem affinity purification and nanoLC-MS/MS. 109
Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast Cancer 109
Quantitative mapping of RNA-mediated nuclear Estrogen Receptor β interactome in human breast cancer cells 108
iMir: an integrated pipeline for high-throughput analysis of small non-coding RNA data obtained by smallRNA-Seq. 106
RNA sequencing identifies specific PIWI-interacting small non-coding RNA expression patterns in breast cancer. 104
The "busy life" of unliganded estrogen receptors 104
The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting 102
PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach 100
Inhibition of histone methyltransferase DOT1L silences ER gene and blocks proliferation of antiestrogen-resistant breast cancer cells 97
Molecular and Functional Characterization of the Somatic PIWIL1/piRNA Pathway in Colorectal Cancer Cells 97
Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors 93
Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes 90
Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer 89
An overview of candidate therapeutic target genes in ovarian cancer 88
HOME-BIO (sHOtgun MEtagenomic analysis of BIOlogical entities): a specific and comprehensive pipeline for metagenomic shotgun sequencing data analysis 88
Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy 87
Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer 83
Lack of pathogenic mutations in six patients with MMPSI. 81
Identification of Antiestrogen-Bound Estrogen Receptor α Interactomes in Hormone-Responsive Human Breast Cancer Cell Nuclei 81
Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1 79
Pesticide toxicogenomics across scales: In vitro transcriptome predicts mechanisms and outcomes of exposure in vivo 75
Integrated Analysis of the Estrogen-Responsive Transcriptome and Estrogen Receptor (ER)-α Binding to Chromatin in Breast Cancer Cells. 73
Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays. 73
Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers 73
Leptin Signaling Contributes to Aromatase Inhibitor Resistant Breast Cancer Cell Growth and Activation of Macrophages 71
Regulation of metabolic reprogramming by long non-coding rnas in cancer 71
MicroRNA Regulation of the Hyper-Proliferative Phenotype of Vascular Smooth Muscle Cells in Diabetes Mellitus 68
Targeted molecular profiling of epithelial ovarian cancer from Italian BRCA wild-type patients with a BRCA and PARP pathways gene panel 67
Analisi dei miRNA come possibili biomarcatori per la diagnosi dei tumori neuroendocrini 66
The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells 63
LncRNA PVT1 links estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancer 62
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer 56
Functional Relationships between Long Non-Coding RNAs and Estrogen Receptor Alpha: A New Frontier in Hormone-Responsive Breast Cancer Management 56
Integrated Analysis of Estrogen -Responsive Transcriptome and Estrogen Receptor alpha Binding to Chromatin in Breast Cancer Cells. 54
Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer 53
BRPF1 inhibition reduces migration and invasion of metastatic ovarian cancer cells, representing a potential therapeutic target 52
Caratterizzazione genomica e trascrittomica di tumori neuroendocrini gastro-enteropancreatici 51
Genome-wide DNA methylation changes upon DOT1L inhibition in hormone-responsive breast cancer cells 50
Integration of miRNA:mRNA Co-Expression Revealed Crucial Mechanisms Modulated in Immunogenic Cancer Cell Death 46
BRPF1 in cancer epigenetics: a key regulator of histone acetylation and a promising therapeutic target 33
Totale 13.109
Categoria #
all - tutte 36.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.042


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021231 0 0 0 0 0 0 38 8 78 9 49 49
2021/2022421 14 0 2 1 34 7 3 15 51 49 65 180
2022/2023899 69 100 40 131 85 150 12 103 128 8 51 22
2023/2024410 36 41 32 17 31 70 55 18 4 14 16 76
2024/20251.215 20 10 6 35 84 132 233 80 217 70 188 140
2025/20267.640 1.043 2.674 2.797 315 533 277 1 0 0 0 0 0
Totale 13.109